So far, no studies have shown that the anti-malarial drug can fight Covid-19, and agency officials say its potential benefits do not outweigh its risks. 
 Learn more about your ad choices. Visit <a href="https://podcastchoices.com/adchoices">podcastchoices.com/adchoices</a>

So far, no studies have shown that the anti-malarial drug can fight Covid-19, and agency officials say its potential benefits do not outweigh its risks. Learn more about your ad choices. Visit podcastchoices.com/adchoices

So far, no studies have shown that the anti-malarial drug can fight Covid-19, and agency officials say its potential benefits do not outweigh its risks. 
 Learn more about your ad choices. Visit <a href="https://podcastchoices.com/adchoices" rel="noopener noreferrer">podcastchoices.com/adchoices</a>

The FDA Revokes Its Emergency Use Authorization for Hydroxychloroquine

Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.

Share The FDA Revokes Its Emergency Use Authorization for Hydroxychloroquine

Sign up to save your podcasts

The FDA Revokes Its Emergency Use Authorization for Hydroxychloroquine

The FDA Revokes Its Emergency Use Authorization for Hydroxychloroquine

More shows like Science, Spoken

This American Life

Freakonomics Radio

Dr Karl Podcast

What's New

Business, Spoken

Security, Spoken

Citadel Dropouts: a Game of Thrones Podcast